Cancer diagnostics is the process of detecting various biomarkers, proteins, and certain symptoms that result in the detection of presence of cancerous tumor in patients. Effective diagnostic testing is used to confirm or eliminate the presence of disease, monitor the disease process, and plan and evaluate the effectiveness of treatment. Diagnostic procedures for cancer may include imaging, laboratory tests (including tests for tumor markers), tumor biopsy, endoscopic examination, surgery, or genetic testing. The cancer diagnostics market report covers revenue generated from sales of product and their applications for cancer diagnostics. Products include consumables and instruments. Further, consumables are divided into antibodies, kits & reagents, and other consumables. Instruments include pathology-based instruments, imaging instruments, and biopsy instruments. Further, applications of cancer diagnostics are breast cancer, lung cancer, blood cancer, colorectal cancer, skin cancer, ovarian cancer, prostate cancer, kidney cancer, liver cancer, pancreatic cancer, cervical cancer, and others. However, the report excludes revenue generated from cancer therapeutics.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: CANCER DIAGNOSTICS MARKET, BY PRODUCT 

CHAPTER 5: CANCER DIAGNOSTICS MARKET, BY APPLICATION

CHAPTER 6: CANCER DIAGNOSTICS MARKET, BY END USE

CHAPTER 7: CANCER DIAGNOSTICS MARKET, BY REGION

CHAPTER 8: COMPANY PROFILES